Monday, 2 November 2026

diarioempresas

IBEX 3518.957,80▲ +1,63%EuroStoxx 506176,06▲ +0,73%S&P 5007541,87▼ -0,50%€/$1,1196▲ +0,27%Brent104,00▼ -8,31%Bitcoin68.485▼ -2,34%
Breaking

Immunoglobulins

Latest Immunoglobulins news

1 article

Glass and concrete facade of Grifols' corporate headquarters, with the name on the building.

Grifols reports €390 million profit by September and announces a dividend of €0.15

Grifols has earned €390 million by September, a 28.4% increase, reduced its debt to 3.98 times EBITDA, and announced a dividend of €0.15 per share.